Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma × pegfilgrastim × Clear all

Phase

Status

Sponsor Class

OTHER 25 NETWORK 3 INDUSTRY 3 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 2 Lymphoma 1

Interventions

Vinorelbine 3 Gemcitabine 3 Ifosfamide 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 fludarabine phosphate 1 fludarabine 1 entecavir 1 Thiotepa 1 Rituximab 1 Platelet Transfusion 1 Mind-Body Therapies 1 Etoposide 1 Drug Therapy 1 Dietary Supplements 1 Cytarabine 1 Cyclophosphamide 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02488382 2017-10-17

Lonquek for Autologous Stem Cell Mobilization

Sheba Medical Center

Phase 1/2 Unknown

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡